Corient Private Wealth
PMVP icon

Corient Private Wealth’s PMV Pharmaceuticals PMVP Stock Holding History

Corient Private Wealth’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.6K Buy
+15,000
New +$19.1K ﹤0.01% 2786
2025
Q3 		– Sell
-10,000
Closed -$10.6K – 2648
2025
Q2 		$10.6K Hold
10,000
– – ﹤0.01% 2421
2025
Q1 		$10.9K Hold
10,000
– – ﹤0.01% 2263
2024
Q4 		$15.1K Hold
10,000
– – ﹤0.01% 2313
2024
Q3 		$14.9K Hold
10,000
– – ﹤0.01% 2439
2024
Q2 		$16.2K Hold
10,000
– – ﹤0.01% 2299
2024
Q1 		$17K Hold
10,000
– – ﹤0.01% 2266
2023
Q4 		$31K Buy
+10,000
New +$26.5K ﹤0.01% 2218

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Corient Private Wealth's PMVP Position: Q1 2026 in Review

Corient Private Wealth opened a new position in PMV Pharmaceuticals (PMVP) in Q1 2026: 15,000 shares worth $18.6K. The stake represents ﹤0.01% of the portfolio and ranks #2786 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in PMVP as recently as Q2 2025.

Corient Private Wealth first reported a position in PMVP in Q4 2023 and has held it in 8 quarters since. The position peaked at $31K in Q4 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Corient Private Wealth held 15,000 shares of PMV Pharmaceuticals worth $18.6K as of Q1 2026.
  • PMV Pharmaceuticals was a new Corient Private Wealth position in Q1 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2786 holding.
  • Corient Private Wealth first reported a position in PMV Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • Corient Private Wealth's PMV Pharmaceuticals position peaked at $31K in Q4 2023.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.